Vertex Pharmaceuticals (VRTX) Debt to Equity (2009 - 2016)
Vertex Pharmaceuticals (VRTX) recorded quarterly Debt to Equity of $0.22 in Q4 2016, down 9.02% quarter-over-quarter from $0.25 in Q3 2016, and down 16.94% on a YoY basis from $0.27 in Q1 2016.
Vertex Pharmaceuticals (VRTX) Debt to Equity (2009 - 2016) Analysis & Trends
Vertex Pharmaceuticals' Debt to Equity history runs 6 years deep, the most recent figure standing at $0.22 for Q4 2016.
- In Q4 2016, Debt to Equity fell 16.94% year-over-year to $0.22; the TTM figure through Dec 2016 stood at $0.22 (down 16.94% YoY), while the FY2016 annual figure was $0.22, down 16.94% from the prior year.
- Debt to Equity was $0.22 for Q4 2016 at Vertex Pharmaceuticals, down from $0.25 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.3 in Q1 2015 to a low of $0.22 in Q4 2016.
- Historically, Debt to Equity has averaged $0.26 across 3 years, with a median of $0.27 in 2014.
- The sharpest annual moves came in 2015 and 2016: Debt to Equity grew 7.39% in 2015, then dropped 16.94% in 2016.
- A 3-year view of Debt to Equity shows it stood at $0.27 in 2014, then climbed by 0.36% to $0.27 in 2015, then declined by 16.94% to $0.22 in 2016.
- The last three Debt to Equity figures came in at $0.22 (Q4 2016), $0.25 (Q3 2016), and $0.25 (Q2 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 0.22 |
| Sep 30, 2016 | 0.25 |
| Jun 30, 2016 | 0.25 |
| Mar 31, 2016 | 0.27 |
| Dec 31, 2015 | 0.27 |
| Sep 30, 2015 | 0.27 |
| Jun 30, 2015 | 0.28 |
| Mar 31, 2015 | 0.30 |
| Dec 31, 2014 | 0.27 |
| Sep 30, 2014 | 0.25 |
| Sep 30, 2011 | 0.14 |
| Mar 31, 2011 | 0.24 |
| Dec 31, 2010 | 0.15 |
| Sep 30, 2010 | 0.07 |
| Jun 30, 2010 | 0.20 |
| Dec 31, 2009 | 0.13 |